Literature DB >> 25304677

Expression of Yes-associated protein in cervical squamous epithelium lesions.

Hong Xiao1, Lina Wu, Huixia Zheng, Ning Li, Huili Wan, Gang Liang, Yanglu Zhao, Jianfang Liang.   

Abstract

OBJECTIVE: Yes-associated protein (YAP) was defined as a candidate oncogene in multiple cancers. Yet, the role of YAP in cervical cancer is largely unknown. The aim of this study was to determine whether YAP could be used as a predictive biomarker in cervical precancerous lesions.
METHODS: Immunohistochemical analysis of YAP expression was performed in 10 chronic cervicitis, 49 cervical intraepithelial neoplasia (CIN) 1, 55 CIN 2, 34 CIN 3, and 32 cervical squamous cell carcinoma (SCC) samples. Human papillomavirus (HPV) was detected by HPV genotype detection kit in 70 cases including 10 chronic cervicitis cases, 13 CIN 1 cases, 19 CIN 2 cases, 14 CIN 3 cases, and 14 SCC cases. Furthermore, the relationship between YAP expression and HPV integration status was analyzed using Spearman rank correlation coefficient test. RESULT: Samples of chronic cervicitis had negative or weak expression of YAP in cytoplasm. In the CIN 1 group, YAP expression was primarily confined to the lower third part of squamous epithelia or basal layer, whereas higher-grade CIN (2 and 3) and SCC groups had a strong nuclear expression of YAP. The expression levels of YAP in chronic cervicitis and CIN 1 were significantly lower compared to those in higher-grade CIN and SCC. Moreover, YAP expression was correlated with HPV integration status. Most high-risk HPV(+)/YAP(+) cases were found in the CIN 3 and SCC groups.
CONCLUSION: This study suggested that YAP could function as a predictive marker in CIN and cervical cancer. YAP expression, in combination of HPV, might facilitate the identification of precancerous cervical lesions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25304677     DOI: 10.1097/IGC.0000000000000259

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  15 in total

1.  Human Papillomavirus 16 E6 Upregulates APOBEC3B via the TEAD Transcription Factor.

Authors:  Seiichiro Mori; Takamasa Takeuchi; Yoshiyuki Ishii; Takashi Yugawa; Tohru Kiyono; Hiroshi Nishina; Iwao Kukimoto
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

2.  Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment.

Authors:  Simonetta Buglioni; Patrizia Vici; Domenico Sergi; Laura Pizzuti; Luigi Di Lauro; Barbara Antoniani; Francesca Sperati; Irene Terrenato; Mariantonia Carosi; Teresa Gamucci; Cristina Vincenzoni; Luciano Mariani; Enrico Vizza; Aldo Venuti; Giuseppe Sanguineti; Angiolo Gadducci; Maddalena Barba; Clara Natoli; Ilio Vitale; Marcella Mottolese; Ruggero De Maria; Marcello Maugeri-Saccà
Journal:  Oncoimmunology       Date:  2016-03-28       Impact factor: 8.110

3.  YAP and TAZ are essential for basal and squamous cell carcinoma initiation.

Authors:  Maud Debaugnies; Adriana Sánchez-Danés; Sandrine Rorive; Maylis Raphaël; Mélanie Liagre; Marie-Astrid Parent; Audrey Brisebarre; Isabelle Salmon; Cédric Blanpain
Journal:  EMBO Rep       Date:  2018-06-06       Impact factor: 8.807

Review 4.  The HIPPO pathway in gynecological malignancies.

Authors:  Dongying Wang; Jiaxing He; Junxue Dong; Thomas F Meyer; Tianmin Xu
Journal:  Am J Cancer Res       Date:  2020-02-01       Impact factor: 6.166

Review 5.  YAP/TAZ at the Roots of Cancer.

Authors:  Francesca Zanconato; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Cancer Cell       Date:  2016-06-13       Impact factor: 31.743

6.  The Hippo component YAP localizes in the nucleus of human papilloma virus positive oropharyngeal squamous cell carcinoma.

Authors:  Faisal Alzahrani; Leanne Clattenburg; Shanmugam Muruganandan; Martin Bullock; Kaitlyn MacIsaac; Michael Wigerius; Blair A Williams; M Elise R Graham; Matthew H Rigby; Jonathan R B Trites; S Mark Taylor; Christopher J Sinal; James P Fawcett; Robert D Hart
Journal:  J Otolaryngol Head Neck Surg       Date:  2017-02-22

7.  Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression.

Authors:  Ming-Xin Cao; Wei-Long Zhang; Xiang-Hua Yu; Jia-Shun Wu; Xin-Wei Qiao; Mei-Chang Huang; Ke Wang; Jing-Biao Wu; Ya-Jie Tang; Jian Jiang; Xin-Hua Liang; Ya-Ling Tang
Journal:  J Exp Clin Cancer Res       Date:  2020-06-03

8.  Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.

Authors:  Sawako Ono; Keisuke Nakano; Kiyofumi Takabatake; Hotaka Kawai; Hitoshi Nagatsuka
Journal:  Int J Med Sci       Date:  2019-05-28       Impact factor: 3.738

9.  The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression.

Authors:  Chunbo He; Dagan Mao; Guohua Hua; Xiangmin Lv; Xingcheng Chen; Peter C Angeletti; Jixin Dong; Steven W Remmenga; Kerry J Rodabaugh; Jin Zhou; Paul F Lambert; Peixin Yang; John S Davis; Cheng Wang
Journal:  EMBO Mol Med       Date:  2015-11       Impact factor: 12.137

10.  Preserved miR-361-3p Expression Is an Independent Prognostic Indicator of Favorable Survival in Cervical Cancer.

Authors:  Shikai Liu; Lili Song; Hairong Yao; Liang Zhang; Dongkui Xu; Qian Li; Ying Li
Journal:  Dis Markers       Date:  2018-09-23       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.